Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options
- 1 July 1997
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 107 (7) , 855-862
- https://doi.org/10.1097/00005537-199707000-00004
Abstract
Rhinocerebral mucormycosis is recognized as a potentially aggressive and commonly fatal fungal infection. The classic presentation is involvement of nasal mucosa with invasion of the paranasal sinuses and orbit. Mucormycosis is most commonly seen in association with diabetic ketoacidosis, but disease demographics have changed with the onset of AIDS and the advent of powerful immunosuppressive drugs. Treatment includes aggressive debridement, systemic antifungal therapy, and control of underlying comorbid factors. Although surgical intervention remains essential, advances in medical therapy have permitted a more limited surgical approach to minimize functional loss without compromising survival. We present the UCLA experience with rhinocerebral mucormycosis from 1955 to 1995, with emphasis on the evolution of disease presentation and alternative treatment options.Keywords
This publication has 20 references indexed in Scilit:
- Orofacial manifestations of the systemic mycosesJournal of Oral Pathology & Medicine, 1992
- MucormycosisClinical Infectious Diseases, 1992
- Rhinocerebral mucormycosis following bone marrow transplantationJournal of Infection, 1992
- Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)Kidney International, 1989
- Improved Diagnosis and Prognosis of MucormyucosisMedicine, 1986
- Twenty‐Five years experience treating Cerebro‐Rhino‐Orbital mucormycosis.The Laryngoscope, 1984
- Cephalic phycomycosis: A report of eight casesThe Laryngoscope, 1982
- Patient survival factors in paranasal sinus mucormycosisThe Laryngoscope, 1980